Aktionärsstruktur

Inhaber in %
Freefloat 97,13
PRIMECAP Management Co. 7,31
Massachusetts Financial Services Co. 5,14
Deutsche Asset Management Investment GmbH 4,79
Templeton Global Advisors Ltd. 3,91
BlackRock Fund Advisors 3,45
Templeton Investment Counsel LLC 3,34
The Vanguard Group, Inc. 2,68
Sycomore Asset Management SA 2,64
Hardman Johnston Global Advisors LLC 1,61
Metin Colpan, PhD 1,55
DZ PRIVATBANK SA 1,22
Goldman Sachs & Co. LLC (Private Banking) 1,13
Frontier Capital Management Co. LLC 1,09
SSgA Funds Management, Inc. 1,01

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2013 2014 2015 2016 2017
Personal am Ende des Jahres 4.015 4.339 4.559 4.684 4.688
Umsatz pro Mitarbeiter in Mio. EUR 0,32 0,31 0,28 0,29 0,30

Bilanz (in Mio. EUR) - Aktiva

2013 2014 2015 2016 2017
Summe Umlaufvermögen 920 1.095 961 1.037 1.647
Summe Anlagevermögen 4.088 4.606 4.190 4.308 5.039
Summe Aktiva 4.088 4.606 4.190 4.308 5.039

Bilanz (in Mio. EUR) - Passiva

2013 2014 2015 2016 2017
Gesamtverschuldung/ -verbindlichkeiten 920 1.095 961 1.037 1.647
Summe Fremdkapital 4.088 4.606 4.190 4.308 5.039
Summe Eigenkapital 4.088 4.606 4.190 4.308 5.039
Summe Passiva 4.088 4.606 4.190 4.308 5.039

Adresse

Hulsterweg 82, 5912 PL Venlo
Telefon 31773556600
Fax 31773556658
Internet http://www.qiagen.com

Management

Alexandra Koenig
Investor Relations Coordinator
Bradford J. Crutchfield
Senior VP-Life Sciences Business Area
Douglas Liu, MBA
Senior Vice President-Global Operations
Elaine R. Mardis, PhD
Independent Member-Supervisory Board
Elizabeth E. Tallett
Independent Member-Supervisory Board
John Gilardi
VP-Corporate Communications & Investor Relations
Lawrence A. Rosen, MBA
Independent Member-Supervisory Board
Manfred E. Karobath, MD
Chairman-Supervisory Board
Manuel O. Mendez, MBA
Senior Vice President-Global Commercial Operations
Metin Colpan, PhD
Independent Member-Supervisory Board
Peer Michael Schatz, MBA
Chief Executive Officer
Roland Sackers, MBA
Chief Financial Officer
Ross L. Levine, MD
Independent Member-Supervisory Board
Sarah Fakih, PhD
Associate Director-Investor Relations
Stéphane Bancel, MBA
Member-Supervisory Board
Sven Håkan Björklund MD, PhD
Member-Supervisory Board
Thomas Schweins, PhD
SVP-Life Science Business Area & Human Resources
Thomas Theuringer, PhD
Director-Public Relations